Patents by Inventor Tuula Ryde

Tuula Ryde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOPARTICULATE MELOXICAM FORMULATIONS
    Publication number: 20210113580
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: June 5, 2020
    Publication date: April 22, 2021
    Inventors: Eugene R. COOPER, Tuula RYDE, John PRUITT, Laura KLINE
  • Nanoparticulate meloxicam formulations
    Patent number: 10709713
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: August 25, 2019
    Date of Patent: July 14, 2020
    Assignee: BAUDAX BIO, INC.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20200155564
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: July 10, 2019
    Publication date: May 21, 2020
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20190381062
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: August 25, 2019
    Publication date: December 19, 2019
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate meloxicam formulations
    Patent number: 10471067
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: November 12, 2019
    Assignee: Recro Pharma, Inc.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate meloxicam formulations
    Patent number: 10463673
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: November 5, 2019
    Assignee: Recro Pharma, Inc.
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20180228810
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: April 11, 2018
    Publication date: August 16, 2018
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20180228809
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: April 11, 2018
    Publication date: August 16, 2018
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • Nanoparticulate Meloxicam Formulations
    Publication number: 20170157061
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: February 21, 2017
    Publication date: June 8, 2017
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150320682
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: May 15, 2015
    Publication date: November 12, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9107827
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: August 18, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9101540
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: August 11, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9101549
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: August 11, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9044396
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: June 2, 2015
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • Nanoparticulate megestrol formulations
    Patent number: 9040088
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: May 26, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150086635
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: March 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150056287
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: February 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MEGESTROL FORMULATIONS
    Publication number: 20150056286
    Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: November 7, 2014
    Publication date: February 26, 2015
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Douglas Hovey, John Pruitt, Tuula Ryde
  • NANOPARTICULATE MELOXICAM FORMULATIONS
    Publication number: 20140141083
    Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: July 12, 2013
    Publication date: May 22, 2014
    Inventors: Eugene R. Cooper, Tuula Ryde, John Pruitt, Laura Kline
  • LOW VISCOSITY LIQUID DOSAGE FORMS
    Publication number: 20130251805
    Abstract: The present invention relates to liquid dosage forms of nanoparticulate active agents having very low viscosities.
    Type: Application
    Filed: December 7, 2012
    Publication date: September 26, 2013
    Applicant: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Tuula RYDE, Niels P. Ryde, H. William Bosch, John D. Pruitt, Christian F. Wertz